NextCure Inc. Common Stock (NASDAQ: NXTC)
Company Name:NextCure Inc. Common Stock
Stock Symbol:NASDAQ: NXTC
Class Period Start:11/05/2019
Class Period End (inclusive):07/14/2020
Filing Deadline:11/20/2020
According to the Complaint, NextCure, Inc. is a clinical-stage biopharmaceutical company striving to discover and develop novel, first-in-class immunomedicine to treat cancer and other immune-related diseases by restoring normal immune function.